Adam Hochron

No matter what age a patient with epilepsy is treating them can be a delicate process. That is perhaps never more true than when the patient is a child dealing with seizures and looking for answers from doctors.

Super refractory status epilepticus is a condition where patients can have seizures lasting anywhere from hours to months. While a developing treatment would only be used in the intensive care unit it could help patients in a very vulnerable health condition.

Epilepsy is a problem for patients around the world and how they are treated for the condition can vary as widely as where they are seeking that treatment.

It was not that long ago that PCSK9 inhibitors were just an idea being discussed in the field of cardiology. Just a few months ago the FDA approved the first treatments which has meant answers to many questions with some questions still remaining.

Patients living with seizure clusters have very limited treatment options for their condition. Researchers are working on developing a nasal spray which could provide acute relief for these patients.

A condition like epilepsy requires a successful working relationship between the patients and their health care professionals, including the ability to communicate effectively a recent study showed that that is an area of concern in the field.

The longer a patient lives with epilepsy the more damage their brain can take from the countless seizures they endure. Recent research has shown that the condition can also cause a patient's brain to age beyond their years as a result of these seizures.

Treating epilepsy can be an effort in individualized medicine with different patients reacting differently to the various seizure medications available. Finding the right one can often determine a patient's quality of life moving forward after diagnosis.

Sometimes when a patient with epilepsy has a seizure they may not even recognize it for any number of reasons. A device no bigger than a piece of gum which is being developed could help in that effort going forward.

There are many factors to consider when treating patients with epilepsy, from the number of medications they take to the impact of the condition on their daily lives. All these factors can help determine their overall quality of life.

There are many factors to consider when treating patients with epilepsy, from the number of medications they take to the impact of the condition on their daily lives. All these factors can help determine their overall quality of life.

Focal epilepsy is just one form of the condition which can affect patients of all ages. Recent research into what may cause the condition and what can be done to treat it focused on a gene known as CLOCK.

Even in hospital settings patients can suffer fatal cardiac events if they are not properly monitored. This is especially true at night when staffing numbers drop and families are not with their loved ones until morning.

In the history of military medicine amputation has been a common practice through the years. As technology has developed work has been done to see whether limbs that might have otherwise been amputated in the past can in fact be salvaged in some way going forward.

Located on the campus of the Brooke Army Medical Center in San Antonio the Center for the Intrepid is an inspiring facility in the world of military medicine helping wounded service members move forward after amputations.

As the only level one trauma center in the Department of Defense doctors at Brooke Army Medical Center often see the most badly wounded service members coming in from all over the world. How they treat those patients can help improve care in local civilian trauma centers and emergency departments in the future.

Located in San Antonio Brooke Army Medical Center has undergone considerable changes since opening nearly 20 years ago. Those changes have meant better care not only for their local patients but also service members who are sent there from all over the world on a daily basis.

Hepatologists around the world are seeing an influx of patients with various liver conditions including non-alcoholic fatty liver disease. Finding ways to treat these patients has become a growing area of the field. These issues are the same whether doctors are treating military patients or those in civilian practice alike.

With soldiers, sailors, and airmen deploying overseas their physical condition when they come back can be vastly different from when they first left. Finding the best ways to treat these patients has been the focus of recent studies on this topic.

As new medications are approved for patients with allergies and asthma it becomes more important that doctors are able to provide them with the key information about these therapies and what it can mean for their overall care.

Conditions like asthma and seasonal allergies can start when a patient is very young and stay with them throughout the course of their lives. As a result careful monitoring and treatment can greatly help improve the quality of life for those patients.

Many pulmonologists when treating a patient could focus their attention either on asthma or COPD. However, a growingly common patient pool is emerging with symptoms resulting from a combination of the two difficult conditions.

For patients with seasonal allergies the prescription medications available may not be enough to help with their symptoms and shots may not be an option they want to consider. Newly developed sublingual immunotherapies have been developed to help these patients manage their daily lives.

When treating liver disease every advantage can help doctors get their patients the care they need before the condition progresses further. A recent study looked at the potential of developing a scoring system to look at risks for this patient population.

In the past patients with alcoholic liver disease may not have been considered viable options for liver transplants. A recent study looked at whether an artificial device could help these patients return to a normal quality of life.

While there are currently no approved treatments for nonalcoholic steatoheptitis there are medications working their way through the approval process including at least a few in phase III studies.

It may be the second most common genotype of hepatitis C but for patients diagnosed with genotype 3 it is also proving to be considerably harder to treat than genotype 1 which has a cure rate near 90%.

When teenage boys in Sweden were required to take part in the conscription process for the country's armed forces only a small percentage were considered overweight or obese. As a result researchers were able to make a connection between those patients and those who developed serious liver disease later in life.

With a population of more than 1.4 million people it is important for patients to be treated as effectively as possible to help their own health as well as prevent their conditions from spreading. A new study looked at bringing help to hepatitis C patients in this growing country.

In the effort to help the growing number of people with liver disease new medications are constantly being developed. This is true for a wide range of conditions including cirrhosis and fibrosis.